Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone vs Hydromorphone QT Interval Effect
NCT03893734Phase 4Recruiting
- Sponsor
- Endeavor Health
- Start
- May 2018
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methadone in postoperative pain (2 arms), sponsored by Endeavor Health. Primary endpoint: QT prolongation on the EKG 30 minutes after postanesthesia care unit admission. Started May 2018; status: recruiting.
02
Drugs
methadone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03893734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03893734.